This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering
Antibody Engineering and Therapeutics

Antibody Engineering & Therapeutics 2021: The Rewind

Posted by on 21 February 2022
Share this article

In December 2021, Antibody Engineering & Therapeutics hybrid conference took place online and in San Diego. Sessions exploring topics across antibody-based drug production were led by 135+ speakers from around the industry.

The comprehensive program boasted fascinating insights shared by the likes of Kristian Andersen (Scripps Research), James Wells (UCSF), Aviv Regev (Genentech Research & Early Development) and many more.

Join us as we take a look back at the highlights from the week, including the most captivating keynotes, the scientific poster presentation hall and reflective insights from AbCellera.

Click the image below or here to explore the report, or download a PDF version using the 'Download Now' link at the top of the page.

Share this article